Literature DB >> 20202284

Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users.

E Lloyd-Smith1, M W Hull, M W Tyndall, R Zhang, E Wood, J S G Montaner, T Kerr, M G Romney.   

Abstract

Injection drug users (IDUs) have an elevated risk for carriage of Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA). Cutaneous injection-related infections are common in IDUs but detailed studies are few. Based on a subsample of 218 individuals from a community-recruited cohort of IDUs at a supervised injection facility, we investigated the microbiology and related antibiotic susceptibility profiles of isolates from 59 wounds. Twenty-seven percent of subjects had at least one wound and 25 (43%) were culture positive for S. aureus alone [14 MRSA and 11 (19%) methicillin-susceptible (MSSA) isolates]. Sixteen of 18 MRSA isolates were classified as community associated (CA) by the presence of genes encoding for PVL. MRSA and MSSA occurred in mixed infection with other organisms on three and six occasions, respectively. All CA-MRSA isolates were susceptible to tetracycline, vancomycin and linezolid but only 13% were susceptible to clindamycin compared to 63% of MSSA isolates. The frequency of CA-MRSA is a cause for concern in wound infection in the IDU setting.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20202284     DOI: 10.1017/S0950268810000464

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  14 in total

1.  Cutaneous diphtheria in the urban poor population of Vancouver, British Columbia, Canada: a 10-year review.

Authors:  C F Lowe; K A Bernard; M G Romney
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

Review 2.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

3.  Skin and needle hygiene intervention for injection drug users: results from a randomized, controlled Stage I pilot trial.

Authors:  Kristina T Phillips; Michael D Stein; Bradley J Anderson; Karen F Corsi
Journal:  J Subst Abuse Treat       Date:  2012-02-14

4.  Use of on-site detoxification services co-located with a supervised injection facility.

Authors:  Andrew Gaddis; Mary Clare Kennedy; Ekaterina Nosova; M-J Milloy; Kanna Hayashi; Evan Wood; Thomas Kerr
Journal:  J Subst Abuse Treat       Date:  2017-08-08

5.  Bedbugs as vectors for drug-resistant bacteria.

Authors:  Christopher F Lowe; Marc G Romney
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

6.  Co-blockade of mecR1/blaR1 signal pathway to restore antibiotic susceptibility in clinical isolates of methicillin-resistant Staphylococcus aureus.

Authors:  Zheng Hou; Ying Zhou; Haifang Wang; Hui Bai; Jingru Meng; Xiaoyan Xue; Xiaoxing Luo
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

7.  Reduction in community-onset methicillin-resistant Staphylococcus aureus rates in an urban Canadian hospital setting.

Authors:  A Wilmer; E Lloyd-Smith; M G Romney; S Champagne; T Wong; W Zhang; R Stenstrom; M W Hull
Journal:  Epidemiol Infect       Date:  2013-06-28       Impact factor: 4.434

8.  Molecular epidemiology and antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus blood culture isolates: results of the Quebec Provincial Surveillance Programme.

Authors:  S Lévesque; A M Bourgault; L A Galarneau; D Moisan; F Doualla-Bell; C Tremblay
Journal:  Epidemiol Infect       Date:  2014-08-20       Impact factor: 4.434

9.  Carriage of methicillin-resistant Staphylococcus aureus by wild urban Norway rats (Rattus norvegicus).

Authors:  Chelsea G Himsworth; Ruth R Miller; Vincent Montoya; Linda Hoang; Marc G Romney; Ghada N Al-Rawahi; Thomas Kerr; Claire M Jardine; David M Patrick; Patrick Tang; J Scott Weese
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

10.  Recurring Severe Injection-Related Infections in People Who Inject Drugs and the Need for Safe Injection Sites in Madrid, Spain.

Authors:  Jorge Valencia; Jesús Troya; Jeffrey V Lazarus; Guillermo Cuevas; Alejandro Alvaro-Meca; Juan Torres; Carlos Gardeta; David Lozano; Santiago Moreno; Pablo Ryan
Journal:  Open Forum Infect Dis       Date:  2021-05-25       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.